FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data
This article was originally published in The Tan Sheet
Executive Summary
FDA's recent decision that the breakthrough UVA filtering ingredient ecamsule is eligible for inclusion in the OTC sunscreen drug monograph pending a safety and efficacy evaluation could level the playing field among competing manufacturers in the U.S. and offer innovators more flexibility
You may also be interested in...
L’Oreal Falls Short On Safety, Efficacy, Adverse Event Data
FDA says it needs additional data from L’Oreal on safety, efficacy and adverse events to determine GRASE for drometrizole trisiloxane.
L’Oreal Falls Short On Safety, Efficacy, Adverse Event Data
FDA says it needs additional data from L’Oreal on safety, efficacy and adverse events to determine GRASE for drometrizole trisiloxane.
L'Oreal's Mexoryl UV Filter Eligible For Sunscreen Monograph - FDA
FDA found L'Oreal's organic UV filter drometrizole trisiloxane, marketed as Mexoryl XL, eligible for possible inclusion in the OTC sunscreen drug monograph and seeks safety and effectiveness data for the ingredient in concentrations up to 15 percent